Top Markets
#1 Helium Helium +60.93%
#2 GEKKO GEKKO +48.56%
#3 Pons Pons +41.70%
#4 ADO Protocol ADO Protocol +39.04%
#5 Prom Prom +37.33%
#6 TENDIES TENDIES +31.81%
#7 StonkBroker StonkBroker +30.27%
#8 Collector Crypt Collector Crypt +29.05%
#9 Collect on Fanable Collect on Fanable +23.84%
#10 龙虾 (Lobster) 龙虾 (Lobster) +21.43%
Coin of the day
Helium Helium
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Pozycja w akcjach #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Cena akcji
$45.64
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$969.02M
Zmiana (1 dzień)
-1.20%
Zmiana (1 rok)
146.66%
Kraj
KR
Handel Orum Therapeutics, Inc. (475830)

Kategoria

Healthcare
Historia stopy dywidendy dla Orum Therapeutics, Inc. (475830)
Stopa dywidendy (TTM) dla Orum Therapeutics, Inc. (symbol akcji: 475830) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Orum Therapeutics, Inc. (475830) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH